Aims: Doxorubicin (Dox) is a potent anti-cancer agent which is widely used in the treatment of a variety of cancers but its usage is limited by cumulative dose-dependent cardiotoxicity mainly due to oxidative damage. Ataxia telangiectasia mutated (ATM) kinase is thought to play a role in mediating the actions of oxidative stress. Here, we show that ATM in cardiac fibroblasts is essential for Dox-induced cardiotoxicity.
Introduction
Doxorubicin (Dox) is a widely used anti-cancer chemotherapeutic agent. Unfortunately, its use is also limited by cumulative dose-dependent cardiotoxic effects which lead to cardiac dysfunction, cardiomyopathy, and eventually severe heart failure and death. 1 Although the precise mechanisms underlying Dox-induced cardiotoxicity are not completely understood, most studies favor that free radical-induced oxidative stress plays a pivotal role, as Dox possesses a chemical structure that generates reaction oxygen species (ROS) during drug metabolism. Most by guest on February 10, 2016 Downloaded from Accepted Manuscript studies both in vitro and in vivo suggest that Dox-induced cardiotoxicity is associated with cardiomyocyte apoptosis and necrosis. [2] [3] [4] [5] Ataxia telangiectasia mutated (ATM) kinase is a member of the phosphoinositide 3-kinase (PI3-kinase)-related protein kinase (PIKK) family which has been identified as the product mutated or inactivated in ataxia telangiectasia (A-T) patients. A key mediator of the DNA damage response is ATM kinase, which has been implicated in playing a central role in response to oxidative stress. [6] [7] [8] Our previous studies showed that ATM mediates an instructive role in oxidative stress-induced endothelial dysfunction and premature senescence. 9 However, the role of ATM in oxidative stress-induced Dox cardiotoxicity has remained elusive.
The heart is comprised of cardiomyocytes as well as interstitial fibroblasts in addition to other cells. The uninjured adult murine myocardium is composed of roughly 56% myocytes, 27% fibroblasts, 7% endothelial cells and 10% vascular smooth muscle cells as well as other immune cells. 10 Studies on the heart have historically focused in main on cardiomyocytes, but the role of cardiac fibroblasts has received increasing recent attention as pivotal functions in the maintenance of cardiac function, physiological cardiac remodeling after heart stress and pathological remodeling have been demonstrated. 11 In the present study, we hypothesized that ATM kinase might mediate effects of oxidative stress in Dox-induced cardiotoxicity, and investigated whether this molecule, as an oxidative stress-sensing molecule, mediates the cardiotoxic effects of the oxidative agent, anthracycline.
ATM indeed mediated the effects of Dox-induced cardiotoxicity, but interestingly, these effects were mediated specifically through the cardiac fibroblast as shown using conditional knockout mice. Further, a specific antagonist against ATM, KU55933, prevented Dox-induced cardiotoxicity. We, therefore, found that ATM is a mediator of Dox-induced cardiotoxicity, by guest on February 10, 2016 identified cell type-specific mechanisms, and showed that ATM is a viable target for potential therapeutic exploitation.
Methods

Animal experiments
C57BL/6 mice were purchased from CLEA Japan. Atm-knockout mice (129S6/SvEvTac-Atm tm1Awb /J) were obtained from Jackson Laboratory. All generations were from matings of heterozygous parents. Age-matched eight-week-old specific pathogen free male wild-type and Atm homozygous knockout mice (Atm 
Statistical analysis
All values are expressed as means ± s.d. Differences between two groups were analyzed using a non-parametric test (two-tailed Mann-Whitney U-test). Comparisons between multiple groups were done using one-way or two-way ANOVA followed by a post hoc Tukey's multiple comparisons test. Survival curves after Dox injection were created using the Kaplan-Meier method and compared by a log-rank test. All data were analyzed using Prism 6.0 (GraphPad Software) for Windows. P values less than 0.05 were considered statistically significant.
A detailed description of the methods is provided in Supplementary Materials.
Results
ATM plays an important role in Dox-induced cardiotoxicity
Previous studies implicated oxidative stress as a major factor involved in Dox-induced cardiotoxicity.
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The DNA damage response and its main signaling pathway involving ATM has been implicated in playing a central role in mediating the actions of oxidative stress. [6] [7] [8] We first tested the involvement of oxidative stress and ATM kinase in Dox-induced cardiotoxicity.
by guest on February 10, 2016 Oxidative stress, which was assessed by 2', 7'-dichlorofluorescein (DCF) fluorescence using CM-H2DCFDA, 15 was attenuated by a free radical scavenger N-acetyl-L-cysteine (NAC) but not by an ATM kinase inhibitor, KU55933 (see Supplementary material online, Figure S1A and B).
Dox-induced ATM phosphorylation, however, was attenuated both by NAC and KU55933 (see Supplementary material online, Figure S1C ), thus indicating that ATM is situated downstream of oxidative stress in Dox-induced cardiotoxicity. To characterize the role of ATM in Dox-induced cardiotoxicity in vivo, mice were treated once with Dox (15 mg/kg of body weight by single i.p. injection) and then sacrificed after 7 days and analyzed. Although no apparent differences were seen in cardiac morphology (see Supplementary material online, Figure S2A ) between wild-type mice and Atm homozygous knockout mice (Atm
), Atm -/-mice showed less decrease in heart weight/body weight (HW/BW) ratio ( Figure 1A ), less increase in cardiac apoptosis ( Figure 1B and C), less impairment of cardiac systolic function ( Figure 1D and E and see Supplementary material online, Table S) , less compensatory dilatation of the left ventricle and less bradycardia (see Supplementary material online, Figure S2B and treatment on the basis that phosphorylated ATM (ATM-S1981) was localized to cells that stained positive for vimentin which was used as a marker to identify fibroblasts (see Supplementary material online, Figure S5A and B). Moreover, ATM and phosphorylated ATM induced by Dox were more robustly expressed in cardiac fibroblasts than in cardiomyocytes in vitro (see Supplementary material online, Figure S5C ). Fibroblasts appeared to be the key lineage responsible for Dox-induced cardiotoxicity through ATM likely due to higher levels of expression and activation of the protein in that cell.
Cardiac fibroblast-specific deleted Atm mice ameliorates depression of left ventricular function, cardiac apoptosis and mortality in response to Dox
As ATM activation was seen mainly in fibroblasts, which suggests that its function in these cells might contribute to the phenotypes seen in Atm -/-mice, the function of ATM in cardiac fibroblasts was next investigated using cell-specific conditional knockout mice. For this, cardiac fibroblast-specific Atm-deleted mice (hereafter referred to as Atm fl/fl ;Postn-Cre) were generated using Atm fl/fl mice 12 crossed with fibroblast-restricted Cre transgenic mice (Postn-Cre) mice. 13 Periostin (which is encoded by Postn) was selectively induced in cardiac fibroblasts following Dox treatment (mRNA expression in Figure 2A , protein expression in Figure 2B ).
Cre-recombinase activity in the fibroblasts of Atm fl/fl ;Postn-Cre mice was also confirmed by in situ hybridization and immunohistochemistry (see Supplementary material online, Figure S6A and B). Approximately 80% of the Atm expression was deleted only in cardiac fibroblasts online, Figure S8B and Table S ). However, no apparent differences were seen in the These results support that cardiac fibroblasts are the key lineage responsible for causing Dox-induced cardiotoxicity through ATM.
ATM controls expression of FasL in cardiac fibroblasts that mediate Dox-induced cardiotoxicity
Because earlier studies have suggested that there are paracrine interactions between cardiomyocytes and fibroblasts, 17, 18 we hypothesized that ATM might directly control the expression of paracrine factors in fibroblasts. To test this, antibody array analysis was done which showed marked increases in apoptotic Fas ligand (FasL) after Dox treatment in conditioned media of cardiac fibroblasts which was suppressed by KU55933 (see Supplementary material online, Figure S13A and B). FasL levels secreted from cardiac fibroblasts which were isolated from adult mice after treatment with Dox were also approximately 2-fold higher than in cardiomyocytes (see Supplementary material online, Figure S13C ). FasL as well as its receptor CD95 (Fas) showed increased expression in cardiac fibroblasts in a time-dependent manner after treatment with Dox which was less in cardiomyocytes ( Figure 5A ). Although there were no apparent differences in cardiac morphology (see Supplementary material online, Figure S14A ), mice treated with KU55933 showed less decrease in HW/BW ratio ( Figure   6A ), less increase in cardiac apoptosis ( Figure 6B and C) , less impairment of cardiac systolic function ( Figure 6D and E and see Supplementary material online, Table S ), less compensatory dilatation of the left ventricle and less bradycardia (see Supplementary material online, Figure   S14B and Table S ) and mortality ( Figure 6F ). However, no apparent differences were seen in the percentages of cardiomyocytes and cardiac fibroblasts in the apoptotic cell populations between the two groups (see Supplementary material online, Figures S3E and S4E ). Under these conditions, pre-treatment with KU55933 attenuated Dox-induced activation of ATM ( Figure 6G ) in the heart. Therefore, inhibition of ATM activation by KU55933 is effective in preventing Dox-induced cardiotoxicity in vivo.
Discussion
Anthracyclines, as represented by doxorubicin (Dox), are widely used for cancer therapy with usage limited due to its cumulative dose-dependent cardiotoxicity which leads to irreversible degenerative cardiomyopathy and heart failure in cancer patients. supports a key role for Dox-induced oxidative stress in cardiotoxicity.
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The present study showed that ATM mediates Dox-induced cardiotoxic effects (e.g. cardiac dysfunction, apoptosis, mortality). Further investigations identified that effects of ATM are predominantly mediated by cardiac fibroblasts and not the cardiomyocyte through enhancing release of FasL from the fibroblast which in turn facilitates apoptosis of cardiomyocytes.
Oxidative stress as sensed through ATM mainly in cardiac fibroblasts, therefore, plays an early instructive role in activation of cardiac apoptosis associated with Dox cardiotoxicity. Our results showed that, surprisingly, cardiac fibroblasts and not cardiomyocytes, as would be expected a priori, not only sensed but also acted in a regulatory manner in response to the oxidative stress damage as caused by Dox.
On cell type-specific mechanisms, to our knowledge, this is the first study to have pursued the role of cardiac fibroblasts and factors in these cells in the pathological mechanisms of cardiotoxicity.
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As ATM is one of the factors lying upstream of p53, these findings are supportive of a non-cardiomyocyte mechanism mediated by p53, likely involving but not restricted to the described pathway through the ATM-p53 axis in the fibroblast which seems to be only partially dependent on ATM ( dexrazoxane, which is thought to chelate and reduce the number of metal ions complexed with the anthracyclines and therefore reduce formation of superoxide radical formation, is presently recommended by the ESC for use as a cardioprotective agent for patients receiving these anti-cancer agents.
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KU55933, which inhibited ATM activity and thus was protective against cardiotoxic effects of Dox in the present study, was developed and pursued as a possible anti-cancer drug, in particular in patients with breast cancer. Nonetheless, we have identified a novel cell-specific molecular signaling pathway which might be potentially exploitable for therapeutic purposes.
Conceptually, combined use of anti-cancer agents that inhibit ATM to prevent cardiotoxicity by Dox might allow for effective methods to overcome the limitations of the latter while allowing combined effect of the two anti-cancer agents with possible use of lesser individual dosages through combinatorial sensitization effects.
35,36
Cell-type specific targeted therapy (e.g. fibroblast-specific ATM antagonism), possibly in combination with those targeting other pathways involved in Dox-induced cardiotoxicity (e.g. cardiomyocyte-specific pathways), might pose further therapeutic possibilities as lineage-restricted targets. With newer anti-cancer agents such as trastuzumab, sorafenib and sunitinib also showing cardiotoxic effects but with lesser known mechanisms, similar approaches may have general and wide applicability.
Study Limitations
The findings of the study are limited by the criteria of the employed technical approaches. One is that MHC-Cre-expressing mice are leaky in expression in cardiomyocytes (approximately 30% expression) and are somewhat a hypomorph rather than null deletion which limits the accuracy of the statements made using these mice although this mouse is the best available at this 
